90 related articles for article (PubMed ID: 17032900)
41. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden.
Swedish Organised Service Screening Evaluation Group
Cancer; 2007 Jun; 109(11):2205-12. PubMed ID: 17471486
[TBL] [Abstract][Full Text] [Related]
42. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme.
Ascunce EN; Moreno-Iribas C; Barcos Urtiaga A; Ardanaz E; Ederra Sanz M; Castilla J; Egüés N
J Med Screen; 2007; 14(1):14-20. PubMed ID: 17362566
[TBL] [Abstract][Full Text] [Related]
43. The use of magnetic resonance imaging in breast cancer screening.
Lee CH; Weinreb JC
J Am Coll Radiol; 2004 Mar; 1(3):176-82. PubMed ID: 17411555
[TBL] [Abstract][Full Text] [Related]
44. The Wisconsin Breast Cancer Epidemiology Simulation Model.
Fryback DG; Stout NK; Rosenberg MA; Trentham-Dietz A; Kuruchittham V; Remington PL
J Natl Cancer Inst Monogr; 2006; (36):37-47. PubMed ID: 17032893
[TBL] [Abstract][Full Text] [Related]
45. Epidemiological changes in breast tumours in Italy: the IMPACT study on mammographic screening programmes.
IMPACT WORKING Group
Pathologica; 2011 Oct; 103(5):290-3. PubMed ID: 22393684
[No Abstract] [Full Text] [Related]
46. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing.
Feuer EJ; Etzioni R; Cronin KA; Mariotto A
Stat Methods Med Res; 2004 Dec; 13(6):421-42. PubMed ID: 15587432
[TBL] [Abstract][Full Text] [Related]
47. Projections of the breast cancer burden to U.S. women: 1990-2000.
Kessler LG; Feuer EJ; Brown ML
Prev Med; 1991 Jan; 20(1):170-82. PubMed ID: 2008426
[TBL] [Abstract][Full Text] [Related]
48. Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality.
Cronin KA; Mariotto AB; Clarke LD; Feuer EJ
J Natl Cancer Inst Monogr; 2006; (36):26-9. PubMed ID: 17032891
[TBL] [Abstract][Full Text] [Related]
49. Should we use incidence, survival or mortality to assess breast cancer trends in European women?
Sant M; Francisci S; Capocaccia R; Verdecchia A; Allemani C; Berrino F
Nat Clin Pract Oncol; 2006 May; 3(5):228-9. PubMed ID: 16682983
[No Abstract] [Full Text] [Related]
50. Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem.
Feuer EJ
J Natl Cancer Inst Monogr; 2006; (36):2-6. PubMed ID: 17032887
[No Abstract] [Full Text] [Related]
51. A statistical model of breast cancer tumour growth with estimation of screening sensitivity as a function of mammographic density.
Abrahamsson L; Humphreys K
Stat Methods Med Res; 2016 Aug; 25(4):1620-37. PubMed ID: 23839121
[TBL] [Abstract][Full Text] [Related]
52. [Mammography screening and adjuvant therapy decreases breast cancer mortality].
Potz-Biedermann C
Med Monatsschr Pharm; 2006 Aug; 29(8):312-3. PubMed ID: 16927606
[No Abstract] [Full Text] [Related]
53. Examining accuracy of screening mammography using an event order model.
Paliwal P; Gelfand AE; Abraham L; Barlow W; Elmore JG
Stat Med; 2006 Jan; 25(2):267-83. PubMed ID: 16381074
[TBL] [Abstract][Full Text] [Related]
54. Re: Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
Feigelson HS; Henderson BE; Pike MC
J Natl Cancer Inst; 1997 Dec; 89(23):1810-2. PubMed ID: 9392623
[No Abstract] [Full Text] [Related]
55. Image quality of screening mammography: effect on clinical outcome.
Feig SA
AJR Am J Roentgenol; 2002 Apr; 178(4):805-7. PubMed ID: 11906850
[No Abstract] [Full Text] [Related]
56. The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999.
Kopans DB
Cancer; 2006 Apr; 106(8):1863; author reply 1864. PubMed ID: 16544316
[No Abstract] [Full Text] [Related]
57. Survival and reduction in mortality from breast cancer. Diagnostic practice in the United States is different.
Welch HG
BMJ; 2000 Dec; 321(7274):1471; author reply 1471-2. PubMed ID: 11187948
[No Abstract] [Full Text] [Related]
58. Estimating measures of diagnostic accuracy when some covariate information is missing.
Paliwal P; Gelfand AE
Stat Med; 2006 Sep; 25(17):2981-93. PubMed ID: 16345056
[TBL] [Abstract][Full Text] [Related]
59. Effects of lead time, length bias, and false-negative assurance on screening for breast cancer.
Pelikan S; Moskowitz M
Cancer; 1993 Mar; 71(6):1998-2005. PubMed ID: 8443751
[TBL] [Abstract][Full Text] [Related]
60. The shape of things to come: using models with physiological structure to predict mortality trajectories.
Mangel MM; Bonsall MB
Theor Popul Biol; 2004 Jun; 65(4):353-9. PubMed ID: 15136010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
